Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Trending With Impact: Adjunct Virotherapy Fights Multiple Myeloma

Oncotarget

March 17, 2022
Researchers investigated using oncolytic viruses to treat multiple myeloma—alone and in a combination approach. continue reading »

A Remote Weight Loss Strategy for Breast Cancer Survivors

Trending

March 9, 2022
Researchers discussed the results of a study that compared weight loss interventions among overweight or obese survivors of breast cancer. continue reading »

Behind the Study: Weight Loss Strategies for Breast Cancer Survivors

Oncotarget

March 7, 2022
Dr. Jennifer Sheng from Johns Hopkins School of Medicine details a 2021 editorial she co-authored with Dr. Vered Stearns published by Oncotarget, entitled, “Innovating and expanding weight loss strategies for breast cancer survivors.” continue reading »

Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer?

Oncotarget

February 24, 2022
Researchers determined the prognostic ability of three NOTCH1 gene variants by incorporating them into two non-tumorigenic breast cell lines. continue reading »

Behind the Study: CrkL Required for Donor T Cell Migration

Oncotarget

February 21, 2022
Dr. Mobin Karimi from Upstate Medical University at Syracuse describes the research behind a 2020 paper he co-authored that was published by Oncotarget, entitled, “CrkL is required for donor T cell migration to GvHD target organs.” continue reading »